233 related articles for article (PubMed ID: 11154268)
1. Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene.
Shi O; Morris SM; Zoghbi H; Porter CW; O'Brien WE
Mol Cell Biol; 2001 Feb; 21(3):811-3. PubMed ID: 11154268
[TBL] [Abstract][Full Text] [Related]
2. Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.
Kasten J; Hu C; Bhargava R; Park H; Tai D; Byrne JA; Marescau B; De Deyn PP; Schlichting L; Grody WW; Cederbaum SD; Lipshutz GS
Mol Genet Metab; 2013 Nov; 110(3):222-30. PubMed ID: 23920045
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia.
Deignan JL; Marescau B; Livesay JC; Iyer RK; De Deyn PP; Cederbaum SD; Grody WW
Mol Genet Metab; 2008 Feb; 93(2):172-8. PubMed ID: 17997338
[TBL] [Abstract][Full Text] [Related]
4. Strategies to rescue the consequences of inducible arginase-1 deficiency in mice.
Ballantyne LL; Sin YY; St Amand T; Si J; Goossens S; Haenebalcke L; Haigh JJ; Kyriakopoulou L; Schulze A; Funk CD
PLoS One; 2015; 10(5):e0125967. PubMed ID: 25938595
[TBL] [Abstract][Full Text] [Related]
5. Hyperargininemia due to liver arginase deficiency.
Crombez EA; Cederbaum SD
Mol Genet Metab; 2005 Mar; 84(3):243-51. PubMed ID: 15694174
[TBL] [Abstract][Full Text] [Related]
6. Inducible arginase 1 deficiency in mice leads to hyperargininemia and altered amino acid metabolism.
Sin YY; Ballantyne LL; Mukherjee K; St Amand T; Kyriakopoulou L; Schulze A; Funk CD
PLoS One; 2013; 8(11):e80001. PubMed ID: 24224027
[TBL] [Abstract][Full Text] [Related]
7. Ornithine deficiency in the arginase double knockout mouse.
Deignan JL; Livesay JC; Yoo PK; Goodman SI; O'Brien WE; Iyer RK; Cederbaum SD; Grody WW
Mol Genet Metab; 2006; 89(1-2):87-96. PubMed ID: 16753325
[TBL] [Abstract][Full Text] [Related]
8. Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice.
Hu C; Kasten J; Park H; Bhargava R; Tai DS; Grody WW; Nguyen QG; Hauschka SD; Cederbaum SD; Lipshutz GS
Mol Ther; 2014 Oct; 22(10):1792-802. PubMed ID: 24888478
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy.
Lee EK; Hu C; Bhargava R; Rozengurt N; Stout D; Grody WW; Cederbaum SD; Lipshutz GS
Mol Ther; 2012 Oct; 20(10):1844-51. PubMed ID: 22760543
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency.
Burrage LC; Sun Q; Elsea SH; Jiang MM; Nagamani SC; Frankel AE; Stone E; Alters SE; Johnson DE; Rowlinson SW; Georgiou G; ; Lee BH
Hum Mol Genet; 2015 Nov; 24(22):6417-27. PubMed ID: 26358771
[TBL] [Abstract][Full Text] [Related]
11. Arginases I and II: do their functions overlap?
Cederbaum SD; Yu H; Grody WW; Kern RM; Yoo P; Iyer RK
Mol Genet Metab; 2004 Apr; 81 Suppl 1():S38-44. PubMed ID: 15050972
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for hyperargininemia due to arginase 1 deficiency.
Therrell BL; Currier R; Lapidus D; Grimm M; Cederbaum SD
Mol Genet Metab; 2017 Aug; 121(4):308-313. PubMed ID: 28659245
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of the mouse and rat type II arginase genes.
Iyer RK; Bando JM; Jenkinson CP; Vockley JG; Kim PS; Kern RM; Cederbaum SD; Grody WW
Mol Genet Metab; 1998 Mar; 63(3):168-75. PubMed ID: 9608538
[TBL] [Abstract][Full Text] [Related]
14. The human arginases and arginase deficiency.
Iyer R; Jenkinson CP; Vockley JG; Kern RM; Grody WW; Cederbaum S
J Inherit Metab Dis; 1998; 21 Suppl 1():86-100. PubMed ID: 9686347
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.
Truong B; Allegri G; Liu XB; Burke KE; Zhu X; Cederbaum SD; Häberle J; Martini PGV; Lipshutz GS
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21150-21159. PubMed ID: 31501335
[TBL] [Abstract][Full Text] [Related]
16. Functional consequences of the G235R mutation in liver arginase leading to hyperargininemia.
Lavulo LT; Emig FA; Ash DE
Arch Biochem Biophys; 2002 Mar; 399(1):49-55. PubMed ID: 11883902
[TBL] [Abstract][Full Text] [Related]
17. Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy.
Hu C; Tai DS; Park H; Cantero G; Cantero-Nieto G; Chan E; Yudkoff M; Cederbaum SD; Lipshutz GS
Gene Ther; 2015 Feb; 22(2):111-5. PubMed ID: 25474440
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of hyperargininemia: structure-function consequences of mutations in human liver arginase.
Ash DE; Scolnick LR; Kanyo ZF; Vockley JG; Cederbaum SD; Christianson DW
Mol Genet Metab; 1998 Aug; 64(4):243-9. PubMed ID: 9758714
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of the human type II arginase gene.
Vockley JG; Jenkinson CP; Shukla H; Kern RM; Grody WW; Cederbaum SD
Genomics; 1996 Dec; 38(2):118-23. PubMed ID: 8954792
[TBL] [Abstract][Full Text] [Related]
20. Mouse model for human arginase deficiency.
Iyer RK; Yoo PK; Kern RM; Rozengurt N; Tsoa R; O'Brien WE; Yu H; Grody WW; Cederbaum SD
Mol Cell Biol; 2002 Jul; 22(13):4491-8. PubMed ID: 12052859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
